Prevalence and clinical significance of antibodies to ribonucleoproteins in systemic lupus erythematosus in Malaysia

British Journal of Rheumatology

Volumn 35, Issue 2, 1996, Pages 129-132

  Wang, C L ^a,b   Ooi, L ^a   Wang, F ^a  

^a HOSPITAL KUALA LUMPUR   (Malaysia)

^b RIPAS HOSPITAL   (Brunei Darussalam)

Author keywords

La SSB; Racial comparison; Ro SSA; Sm; Systemic lupus erythematosus; U1RNP

Indexed keywords

AUTOANTIBODY; RIBONUCLEOPROTEIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HONG KONG; HUMAN; IMMUNODIFFUSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RAYNAUD PHENOMENON; SCHOOL CHILD; SEX DIFFERENCE; SINGAPORE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029932379     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.2.129     Document Type: Article

References (21)

1. Fancocur AM, Matthews MB. Cellular protein and RNP antigens in autoimmune disease. Mol Biol Med 1984;2:105-20.
2. Nottman DD, Kurata N, Tan EM. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 1975;83:464-9.
3. Tan EM. Autoantibodies to nuclear antigens: their immunology and medicine. Adv Immunol 1982;33:167-240.
4. Maddison PJ, Mogavero H, Provost TT, Reichlin M. Antibodies to Ro(SSA). The clinical significance of autoantibodies to soluble cytoplasmic antigen in SLE and other connective tissue diseases. J Rheumatol 1979;6:189-95.
5. Dillon CF, Jones JV, Reichlin M et al. Antibodies to Ro in a population of patients with systemic lupus erythematosus: distribution, clinical and serological association. J Rheumatol 1983;10:380-6.
6. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC et al Systemic lupus erythematosus: a review of clinico-laboratory features and immunologic markers in 150 patients with emphasis on demographic subsets. Medicine 1985;64:285-95.
7. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
8. Scopelitis E, Perez M, Biundo JJ. Anti-SSA(Ro) antibody: a connective tissue disease marker. J Rheumatol 1985;12:1105-8.
9. Reichlin M. Clinical and immunological significance of antibodies to Ro and La in systemic lupus erythematosus. Arthritis Rheum 1982;25:767-72.
10. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socio-economic influences. Arch Intern Med 1990;150:849-53.
11. Arnett FC, Hamilton RG, Roebber MG et al. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988;15:1773-6.
12. Hamilton RG, Harley JB, Bias WB et al. Two Ro(SSA) autoantibody responses in systemic lupus erythematosus. Arthritis Rheum 1988;31:496-505.
13. Wilson WA, Scopelitis E, Michalski JP. Association of HLA-DR7 with both antibodies to SSA(Ro) and disease susceptibility in Blacks with systemic lupus erythematosus. J Rheumatol 1984;11:653-7.
14. Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 1988;47:918-23.
15. Lee SS, Li CS, Li CPK. Clinical profiles of Chinese patients with systemic lupus erythematosus. Lupus 1993;2:105-9.
16. Aydintug AO, Domenech I, Cervera R et al. Systemic lupus erythematosus in males: analysis of clinical and laboratory features. Lupus 1992;1:295-8.
17. Koh WH, Fong KY, Boey ML, Feng PH. Systemic lupus in 61 Oriental males. A study of clinical and laboratory manifestations. Br J Rheumatol 1994; 33:339-42.
18. Ward M, Studenski S. Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990;17:220-4.
19. Maddison PJ, Provost TT, Reichlin M. Serological findings in patients with 'ANA-negative' systemic lupus erythematosus. Medicine 1981;60:87-94.
20. Wasicek CA, Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 1982;69: 834-43.
21. Winn DM, Wolfe JF, Lindberg DA et al. Identification of a clinical subset of systemic lupus erythematosus by antibodies to the Sm antigen. Arthritis Rheum 1979;22:1334-7.